<DOC>
	<DOCNO>NCT01153724</DOCNO>
	<brief_summary>This clinical trial intend investigate possible effect CYP 2C9 inhibitor fluconazole bioavailability olodaterol</brief_summary>
	<brief_title>Relative Bioavailability Olodaterol Fluconazole</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<criteria>Inclusion criterion : Healthy male female volunteer</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>